Iovance Biotherapeutics Inc (IOVA)

[badgerkid]

DB, no real concerns and no way to use technical trading for an early commercial stage bio. With each quarter of earnings over the next 3 quarters, the picture will gain additional clarity and investors will be able to more fully appreciate and value the stock. With Q4 and 2025 guidance, I suspect we'll all be very happy with the share price (unless you're expecting over $100 by then - that's going to take a bit more time). I still believe we'll see higher highs yet this year. Hopefully we'll keep seeing higher lows as well.

A buddy likes to remind me that we still want to get to long term capital gains on all of our recent share purchases. I'm good with that. And all signs from the company are positive: their growing and adding new employees, their patient que continues to expand, their generating real revenue, their expanding into additional world markets, and their product lines for additional cancer types will be expanding as well.

You kind of need this daily mantra if you intend to stay long in IOVA.

Have a great weekend and good luck to the longs.